Experimental studies and early-phase clinical trials suggest that mobilization of bone marrow stem cells by granulocyte-colony-stimulating factor (G-CSF) can be used to improve cardiac regeneration ...

We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines. Objective: To examine ...

The impact of post transplant use of G-CSF on event free survival in AML patients undergoing allogeneic stem cell transplantation from unrelated donors and in vivo T-cell depletion with ATG This is an ...

Granulocyte colony-stimulating factor (G-CSF), which causes division and differentiation of bone marrow cells depending on the body's need for leukocytes, has a significant regulatory effect not only ...

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would ...

The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...

The yield of peripheral blood stem cells (PBSC) in hematological or solid tumour patients treated with high dose chemotherapy and hemopoietic growth factors No significant financial relationships to ...

a FDA = Food and Drug Administration, G-CSF = granulocyte colony-stimulating factor, GM-CSF = granulocyte-macrophage colony-stimulating factor, CHO = Chinese hamster ovary, NA = not available.

Severe sepsis from bacterial or viral infections can be life-threatening and even people recovering from severe sepsis may experience long-lasting effects on the immune system, making them more ...